Tennessee has unveiled its proposal to turn the state's Medicaid program into a block grant; the number of abortions across the country have dropped to the lowest levels since the procedure became legal nationwide; New York has temporaily banned the sale of e-cigarettes and nicotine e-liquids.
Months after Governor Bill Lee, R-Tennessee, signed legislation requesting approval from the Trump administration to transition the state’s Medicaid program to a block grant, the state has unveiled its proposal. The proposal needs to be submitted to CMS, and if approved, the state will become the first in the nation to implement the model. The administration has drafted a guidance that would make is easier for states to apply for blocks grants, which has been under review by the White House Office of Management and Budget for months but could be released at any time, according to The Hill.
The number of abortions across the country have dropped to the lowest levels since 1973, when they became legal nationwide, according to a report from the Guttmacher Institute. The report showed that there were 862,000 abortions in the United States in 2017, which is down from 926,000 in 2014 and slightly more than 1 million in 2011. The declines in abortion rates are coming from all parts of the country, and according to the Associated Press, one reason for the decline is that fewer women are becoming pregnant.
New York state health officials have passed an emergency regulation temporarily banning the sale of flavored e-cigarettes and nicotine e-liquids. The members of the states’ Public Health and Health Planning Council that approved the ban argued that it would help mitigate the risk in e-cigarette use among minors, calling it a public health crisis. However, some members of the council said they were torn on the regulation and some said it should have included a ban on menthol e-cigarettes, reported The Wall Street Journal.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Untangling Medical Debt From Credit Scores: Effects So Far and Next Steps
November 29th 2023After recent policy changes removing most medical debts from credit reports, Americans are seeing their credit scores increase, but experts warn of the need to monitor billing and collection practices for unintended consequences.
Read More